Severity of small-for-gestational-age and morbidity and mortality among very preterm neonates

J Perinatol. 2023 Apr;43(4):437-444. doi: 10.1038/s41372-022-01544-w. Epub 2022 Oct 27.

Abstract

Objective: Evaluate the association between small for gestational age (SGA) severity and morbidity and mortality in a contemporary, population of very preterm infants.

Study design: This secondary analysis of a California statewide database evaluated singleton infants born during 2008-2018 at 24-32 weeks' gestation, with a birthweight <15th percentile. We analyzed neonatal outcomes in relation to weight for gestational age (WGA) and symmetry of growth restriction.

Results: An increase in WGA by one z-score was associated with decreased major morbidity or mortality risk (aRR 0.73, 95% CI 0.68-0.77) and other adverse outcomes. The association was maintained across gestational ages and did not differ by fetal growth restriction diagnosis. Symmetric growth restriction was not associated with neonatal outcomes after standardizing for gestational age at birth.

Conclusions: Increasing SGA severity had a significant impact on neonatal outcomes among very preterm infants.

MeSH terms

  • Birth Weight
  • Female
  • Fetal Growth Retardation
  • Gestational Age
  • Humans
  • Infant, Extremely Premature
  • Infant, Newborn
  • Infant, Newborn, Diseases*
  • Infant, Premature, Diseases*
  • Infant, Small for Gestational Age